Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

The IL-3Rα-Targeted Drug SL-401 Selectively Kills Blastic Plasmacytoid Dendritic Cell Neoplasm Cells

Fanny Angelot-Delettre, PhD, Arthur E. Frankel, MD, Jen Sing Liu, PhD, Estelle Seilles, PhD, Sabeha Biichle, Bsc, Bernard Drenou, MD, PhD, Mark L. Jacobson, MA, Thomas P. Cirrito, PhD, Arkam Yazid, MD, Eric Deconinck, MD, PhD, Christopher L. Brooks, PhD, Philippe Saas, PhD, Francine Garnache Ottou, PhD

Blood (2011) 118 (21): 2588.

https://doi.org/10.1182/blood.V118.21.2588.2588

Published: 2011

Journal Articles

A Comparison of the BacT/ALERT Results from Plateletpheresis Units Collected Using Baxter Amicus and Gambro Trima.

Jessica L. Jacobson, MD, Teri O’Brien, Donna Strauss

Blood (2006) 108 (11): 4134.

https://doi.org/10.1182/blood.V108.11.4134.4134

Published: 2006

Journal Articles

Prognostic factors and response to fludarabine therapy in patients with Waldenström macroglobulinemia: results of United States intergroup trial (Southwest Oncology Group S9003)

Madhav V. Dhodapkar, Joth L. Jacobson, Morie A. Gertz, Saul E. Rivkin, G. David Roodman, Joseph M. Tuscano, Muhammad Shurafa, Robert A. Kyle, John J. Crowley, Bart Barlogie

Blood (2001) 98 (1): 41–48.

https://doi.org/10.1182/blood.V98.1.41

Published: 2001

Journal Articles

A variant of von Willebrand's disease with abnormal expression of factor VIII procoagulant activity

RR Montgomery, WE Hathaway, J Johnson, L Jacobson, W Muntean

Blood (1982) 60 (1): 201–207.

https://doi.org/10.1182/blood.V60.1.201.201

Published: 1982

Journal Articles

Antithrombin III deficiency: decreased synthesis of a biochemically normal molecule

DR Ambruso, BD Leonard, RD Bies, L Jacobson, WE Hathaway, EB Reeve

Blood (1982) 60 (1): 78–83.

https://doi.org/10.1182/blood.V60.1.78.78

Published: 1982

NARROW

The IL-3Rα-Targeted Drug SL-401 Selectively Kills Blastic Plasmacytoid Dendritic Cell Neoplasm Cells

A Comparison of the BacT/ALERT Results from Plateletpheresis Units Collected Using Baxter Amicus and Gambro Trima.

Prognostic factors and response to fludarabine therapy in patients with Waldenström macroglobulinemia: results of United States intergroup trial (Southwest Oncology Group S9003)

A variant of von Willebrand's disease with abnormal expression of factor VIII procoagulant activity

Antithrombin III deficiency: decreased synthesis of a biochemically normal molecule

Email alerts

ASH Publications

American Society of Hematology

The IL-3Rα-Targeted Drug SL-401 Selectively Kills Blastic Plasmacytoid Dendritic Cell Neoplasm Cells

A Comparison of the BacT/ALERT Results from Plateletpheresis Units Collected Using Baxter Amicus and Gambro Trima.

Prognostic factors and response to fludarabine therapy in patients with Waldenström macroglobulinemia: results of United States intergroup trial (Southwest Oncology Group S9003)

A variant of von Willebrand's disease with abnormal expression of factor VIII procoagulant activity

Antithrombin III deficiency: decreased synthesis of a biochemically normal molecule

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only